Company intelligence / Profile preview

Arkema

Ownership: Public · AKE
Employees: ~21150
Development stage: Commercial

Overview

Arkema is a global leader in specialty materials and chemicals, focusing on innovative and sustainable solutions across adhesives, advanced materials, and coatings. The company does not develop therapeutics or healthcare products but supplies high-performance materials for various industries including automotive, electronics, construction, packaging, and consumer goods. (Note: Not a life science/pharma company. The summary provided indicates this clearly.)

Industry: Chemicals & Materials

Partnerships

Collaborations with start-ups via the Start-up Connect program

Financials

Market cap: $484.6M
Total revenue: $160.2M
Enterprise value: $396.6M

Beyond the preview

Go deeper on Arkema.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arkema.

Explore the full profile